Holen Sie sich die Stockscreener-App
25.00
1.77%
-0.45
Schlusskurs vom Vortag:
$25.45
Offen:
$25.39
24-Stunden-Volumen:
1.43M
Relative Volume:
0.92
Marktkapitalisierung:
$2.16B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
39.68
EPS:
0.63
Netto-Cashflow:
$170.92M
1W Leistung:
+2.84%
1M Leistung:
-7.27%
6M Leistung:
+8.79%
1J Leistung:
+18.20%
1-Tages-Spanne:
$24.62
$25.39
1-Wochen-Bereich:
$24.10
$25.78
52-Wochen-Spanne:
$17.98
$28.75
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Vergleichen Sie PGNY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
25.00 | 2.19B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
354.47 | 315.01B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
82.68 | 103.45B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
372.24 | 82.20B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
280.39 | 73.44B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
266.29 | 32.55B | 126.36B | 1.30B | 1.55B | 10.67 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
Progyny price target raised to $35 from $30 at BTIG - Yahoo Finance
SG Americas Securities LLC Cuts Stock Position in Progyny, Inc. $PGNY - MarketBeat
Progyny, Inc. (PGNY) supported by analysts as earnings visibility improves - MSN
Progyny, Inc. (PGNY) Supported by Analysts as Earnings Visibility Improves - Yahoo Finance
Progyny Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily
ETF Watch: Is Progyny Inc stock technically oversold2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Progyny (PGNY) Stock Rises on Analyst Upgrade to Market Outperform | 2026 OutlookNews and Statistics - IndexBox
Progyny (PGNY) Stock Is Up, What You Need To Know - Finviz
Progyny sees IBD RS rating climb to 77 - MSN
Forecasting The Future: 6 Analyst Projections For Progyny - Benzinga
Progyny (NASDAQ:PGNY) Upgraded by Citizens Jmp to "Market Outperform" Rating - MarketBeat
Citizens Upgrades Progyny (PGNY) - Nasdaq
PGNY Stock Rating Upgraded by Citizens to Market Outperform | PG - GuruFocus
This Intel Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Progyny stock rating upgraded by Citizens on strong retention rates - Investing.com UK
Progyny Sees IBD RS Rating Climb To 77 - Investor's Business Daily
Progyny president’s employment to end December 2025 - MSN
Short Interest in Progyny, Inc. (NASDAQ:PGNY) Declines By 23.3% - MarketBeat
(PGNY) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Can Progyny’s (PGNY) Modest Guidance Raise Redefine Its Demand Resilience Narrative? - Yahoo Finance
Stock Picks for 2026: e.l.f. Beauty to Buy, American Woodmark & Progyny to SellNews and Statistics - IndexBox
Pullback Watch: Why is Progyny Inc stock going downJuly 2025 Levels & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Progyny Inc (PGNY) Shares Gap Down to $24.7608 on Jan 15 - GuruFocus
Aug Setups: Is Progyny Inc impacted by rising rates2025 Bull vs Bear & Expert Curated Trade Setups - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Regeneron (REGN) and Progyny (PGNY) - The Globe and Mail
Progyny (NASDAQ:PGNY) Reaches New 1-Year HighTime to Buy? - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Progyny Stock (-11%) : JPM Conference Growth Narrative Fails to Impress - Trefis
Progyny (NASDAQ:PGNY) Shares Down 5.9%Time to Sell? - MarketBeat
Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - 富途牛牛
Progyny stock to exceed guidance as BofA reiterates Buy rating By Investing.com - Investing.com Canada
Progyny stock to exceed guidance as BofA reiterates Buy rating - Investing.com
Zacks Industry Outlook Highlights Medpace, Enhabit and Progyny - Yahoo Finance
Progyny to discuss updated financial expectations at upcoming JP Morgan healthcare conference - marketscreener.com
Progyny To Discuss Updated Financial Expectations At Upcoming JP Morgan Healthcare Conference - TradingView — Track All Markets
Progyny Inc anticipates Q4 and full year results to be slightly above previously provided financial guidance - marketscreener.com
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference - The Manila Times
Family-building firm Progyny now expects stronger year-end results - Stock Titan
Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - Yahoo Finance
Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates - sharewise.com
How sustainable is Progyny Inc. stock dividend payout2025 Trading Recap & Fast Moving Stock Watchlists - ulpravda.ru
Why Progyny Inc. stock remains a top recommendationRisk Management & Low Risk Growth Stock Ideas - Улправда
Progyny, Inc. (PGNY) Soars to 52-Week High, Time to Cash Out? - sharewise.com
Progyny stock hits 52-week high at 27.84 USD By Investing.com - Investing.com Nigeria
Why Progyny Inc. stock is seen as undervaluedGap Up & Low Drawdown Investment Ideas - Улправда
Progyny (NASDAQ:PGNY) stock performs better than its underlying earnings growth over last year - Sahm
PGNY: Keybanc Maintains Overweight Rating and Raises Price Targe - GuruFocus
Progyny (PGNY) Stock Hits New High: Keybanc Raises Target to $32News and Statistics - IndexBox
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
Truist Securities upgrades Progyny stock rating to Buy on improved outlook By Investing.com - Investing.com South Africa
Truist Securities upgrades Progyny stock rating to Buy on improved outlook - Investing.com Nigeria
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.88%
1.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):